BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33750368)

  • 1. Analysis of second opinion programs provided by German statutory and private health insurance - a survey of statutory and private health insurers.
    Könsgen N; Prediger B; Bora AM; Glatt A; Hess S; Weißflog V; Pieper D
    BMC Health Serv Res; 2021 Mar; 21(1):209. PubMed ID: 33750368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Compilation of Second Opinion Programs in the German Statutory Health Insurance].
    Pieper D; Heß S; Mathes T
    Gesundheitswesen; 2018 Oct; 80(10):859-863. PubMed ID: 28505704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitude toward second opinions in Germany - a survey of the general population.
    Könsgen N; Prediger B; Schlimbach A; Bora AM; Hess S; Caspers M; Pieper D
    BMC Health Serv Res; 2022 Jan; 22(1):76. PubMed ID: 35033078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The new private health insurance subscribers].
    Uschold P; Potthoff P; von Törne I; Güther B
    Gesundheitswesen; 2005; 67(8-9):594-604. PubMed ID: 16217713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Private health insurance in Germany and Chile: two stories of co-existence, segmentation and conflict.
    Roman-Urrestarazu A; Yang JC; Ettelt S; Thalmann I; Seguel Ravest V; Brayne C
    Int J Equity Health; 2018 Aug; 17(1):112. PubMed ID: 30075777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second opinion programmes in Germany: a mixed-methods study protocol.
    Bruch D; May S; Prediger B; Könsgen N; Alexandrov A; Mählmann S; Voß K; Liersch S; Loh JC; Christensen B; Franzen A; von Peter S; Pieper D; Ronckers C; Neugebauer E
    BMJ Open; 2021 Feb; 11(2):e045264. PubMed ID: 33568378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Communication of Medication Nonmedical Switching Policies and Procedures by Insurance Companies: Results of an E-Survey.
    Salam T; Duhig A; Patel AA; Cameron A; Voelker J; Bookhart B; Coleman CI
    Clin Ther; 2020 Jun; 42(6):1077-1086. PubMed ID: 32418669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging role of the Australian private health insurance sector in providing chronic disease management programs: current activities, challenges and constraints.
    Khoo J; Hasan H; Eagar K
    Aust Health Rev; 2019 Oct; 43(5):572-577. PubMed ID: 30857589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telemedical Second Opinions in Germany: A Customer Survey of an Online Portal.
    Könsgen N; Prediger B; Schlimbach A; Bora AM; Weißflog V; Loh JC; Bruch D; Pieper D
    Telemed J E Health; 2022 Apr; ():. PubMed ID: 35394825
    [No Abstract]   [Full Text] [Related]  

  • 10. The Big Five Health Insurers' Membership And Revenue Trends: Implications For Public Policy.
    Schoen C; Collins SR
    Health Aff (Millwood); 2017 Dec; 36(12):2185-2194. PubMed ID: 29200327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statutory health insurance competition in Europe: a four-country comparison.
    Thomson S; Busse R; Crivelli L; van de Ven W; Van de Voorde C
    Health Policy; 2013 Mar; 109(3):209-25. PubMed ID: 23395277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of the Dutch experience with health insurers acting as healthcare advisors.
    Victoor A; Brabers AEM; van Esch TEM; de Jong JD
    PLoS One; 2019; 14(11):e0224829. PubMed ID: 31703085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expectations of clients, insurers, and providers: a qualitative responsiveness assessment among private health insurance sector in Kampala-Uganda.
    Tindyebwa T; Ssempala R; Ssennyonjo A; Mayora C; Muhoozi M; Tusabe J; Mukama P; Freddie S
    BMC Health Serv Res; 2023 Dec; 23(1):1358. PubMed ID: 38053178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How is enrollees' trust in health insurers associated with choosing health insurance?
    van der Hulst FJP; Brabers AEM; de Jong JD
    PLoS One; 2023; 18(11):e0292964. PubMed ID: 37917768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Competition among health insurers from the perspective of a statutory health insurance company].
    Fischer B
    Z Evid Fortbild Qual Gesundhwes; 2009; 103(10):635-8; discussion 643. PubMed ID: 20120192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morbidity and healthcare differences between insured in the statutory ("GKV") and private health insurance ("PKV") in Germany. Review of empirical studies].
    Huber J; Mielck A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):925-38. PubMed ID: 20853090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inequalities in health risks, morbidity and health care of children by health insurance of their parents (statutory vs. private health insurance): results of the German KiGGS study].
    Huber J; Lampert T; Mielck A
    Gesundheitswesen; 2012 Oct; 74(10):627-38. PubMed ID: 22275061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citizen engagement in healthcare procurement decision-making by healthcare insurers: recent experiences in the Netherlands.
    Brito Fernandes Ó; Bos V; Klazinga N; Kringos D
    Health Res Policy Syst; 2022 Dec; 20(1):137. PubMed ID: 36550520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs, commitment and locality: a comparison of for-profit and not-for-profit health plans.
    Inquiry; 2004; 41(2):116-29. PubMed ID: 15449428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting vaccinations - an analysis of measures taken by German statutory health insurers.
    Damm K; Schubert JM; von der Schulenburg JM
    Health Econ Rev; 2011 Oct; 1(1):16. PubMed ID: 22827933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.